ConductScience.org, home

Paper14739769

Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Peterson JT. Heart Fail Rev, 2004. Cited by 155 papers, by iCite.

Cite this record

ConductScience Library. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Papers, record 14739769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14739769

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.
PubMed
Journal
Heart Fail Rev
PubMed
Year
2004
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
155
iCite
Relative citation ratio, by iCite
3.97
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peterson JTJ Thomas

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiomyopathy, DilatedMajor topic
DoxycyclineMajor topic
Drug DesignMajor topic
Enzyme InhibitorsMajor topic
Matrix Metalloproteinase InhibitorsMajor topic
Collagen
Enzyme Activation
Extracellular Matrix
Humans
Hydroxamic Acids
Matrix Metalloproteinases
Musculoskeletal Diseases
Myocardium
Neoplasms
Periodontal Diseases

Source PubMed

Download CSV of topics

References76

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110415745Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought?Ann N Y Acad Sci1999https://conductscience.org/library/papers/10415745PubMed
210713697The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.Oncogene2000https://conductscience.org/library/papers/10713697PubMed
311865675Increasing throughput in lead optimization in vivo toxicity screens.Curr Opin Drug Discov Devel2002https://conductscience.org/library/papers/11865675PubMed
412096249Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.J Vasc Surg2002https://conductscience.org/library/papers/12096249PubMed
57525108Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors.Circulation1994https://conductscience.org/library/papers/7525108PubMed
611749499Design and therapeutic application of matrix metalloproteinase inhibitors.Chem Rev1999https://conductscience.org/library/papers/11749499PubMed
79724659Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.EMBO J1998https://conductscience.org/library/papers/9724659PubMed
812574145Selective matrix metalloproteinase inhibition with developing heart failure: effects on left ventricular function and structure.Circ Res2003https://conductscience.org/library/papers/12574145PubMed
911801860The use of fibrates and of statins in preventing atherosclerosis in diabetes.Curr Opin Lipidol2001https://conductscience.org/library/papers/11801860PubMed
1012570684Drug discovery today.Curr Top Med Chem2003https://conductscience.org/library/papers/12570684PubMed
1112571631Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.Gene Ther2003https://conductscience.org/library/papers/12571631PubMed
1210415734Preclinical and clinical studies of MMP inhibitors in cancer.Ann N Y Acad Sci1999https://conductscience.org/library/papers/10415734PubMed
13666744Degradation of cartilage proteoglycans by a neutral proteinase secreted by rabbit bone-marrow macrophages in culture.Biochem J1978https://conductscience.org/library/papers/666744PubMed
148093070Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts.Biochem Biophys Res Commun1994https://conductscience.org/library/papers/8093070PubMed
159590175MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.Cell1998https://conductscience.org/library/papers/9590175PubMed
1612388239Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice.Am J Physiol Heart Circ Physiol2003https://conductscience.org/library/papers/12388239PubMed
178910831Periodontal disease and cardiovascular disease.J Periodontol1996https://conductscience.org/library/papers/8910831PubMed
1811060801Ongoing trials with matrix metalloproteinase inhibitors.Expert Opin Investig Drugs2000https://conductscience.org/library/papers/11060801PubMed
199288970Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.Nature1997https://conductscience.org/library/papers/9288970PubMed
2011134178Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice.J Clin Invest2001https://conductscience.org/library/papers/11134178PubMed

See all 76 referencesDownload CSV of references

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.

PMIDTitleJournalYearIn PapersSource
42570066Kinetic and inhibitory profiling of serum MMP-9 in acute spinal cord injury: neurochemical links to injury severity and neuroinflammation.Acta Neurol Belg2026https://conductscience.org/library/papers/42570066PubMed
37108137Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry.Int J Mol Sci2023https://conductscience.org/library/papers/37108137PubMed
36982922New Drugs and Therapies in Pulmonary Arterial Hypertension.Int J Mol Sci2023https://conductscience.org/library/papers/36982922PubMed
36926709Reviving the use of inhibitors of matrix metalloproteases in spinal cord injury: a case for specificity.Neural Regen Res2023https://conductscience.org/library/papers/36926709PubMed
35925539Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation.Daru2022https://conductscience.org/library/papers/35925539PubMed
35742496Tetracyclines-An Important Therapeutic Tool for Dermatologists.Int J Environ Res Public Health2022https://conductscience.org/library/papers/35742496PubMed
35441277Dolichoectasia: a brain arterial disease with an elusive treatment.Neurol Sci2022https://conductscience.org/library/papers/35441277PubMed
33396445The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33396445PubMed
33136210Tetracycline and viruses: a possible treatment for COVID-19?Arch Virol2021https://conductscience.org/library/papers/33136210PubMed
32958629Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.J Pharmacol Exp Ther2020https://conductscience.org/library/papers/32958629PubMed
32233938Matrix Metalloproteinases and Glaucoma Treatment.J Ocul Pharmacol Ther2020https://conductscience.org/library/papers/32233938PubMed
31953328Selective inhibition of matrix metalloproteinase 10 (MMP10) with a single-domain antibody.J Biol Chem2020https://conductscience.org/library/papers/31953328PubMed
31653893Doxycycline reduces osteopenia in female rats.Sci Rep2019https://conductscience.org/library/papers/31653893PubMed
31213768Low-dose doxycycline inhibits hydrogen peroxide-induced oxidative stress, MMP-2 up-regulation and contractile dysfunction in human saphenous vein grafts.Drug Des Devel Ther2019https://conductscience.org/library/papers/31213768PubMed
29393911The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.Int J Mol Sci2018https://conductscience.org/library/papers/29393911PubMed
28754718Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.Am J Physiol Heart Circ Physiol2017https://conductscience.org/library/papers/28754718PubMed
28626528Exploitation of Conformational Dynamics in Imparting Selective Inhibition for Related Matrix Metalloproteinases.ACS Med Chem Lett2017https://conductscience.org/library/papers/28626528PubMed
28413032Matrix Metalloproteinases in Myocardial Infarction and Heart Failure.Prog Mol Biol Transl Sci2017https://conductscience.org/library/papers/28413032PubMed
27509041MMpI: A WideRange of Available Compounds of Matrix Metalloproteinase Inhibitors.PLoS One2016https://conductscience.org/library/papers/27509041PubMed
26269290The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction.IUBMB Life2015https://conductscience.org/library/papers/26269290PubMed

See all 59 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14739769

GET https://conductscience.org/api/papers/v1/14739769/references?page=2